Ubs Oconnor LLC Connect Biopharma Holdings LTD Call Options Transaction History
Ubs Oconnor LLC
- $1.51 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CNTB
# of Institutions
17Shares Held
3.28MCall Options Held
14KPut Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.09MShares$1.7 Million1.79% of portfolio
-
Choreo, LLC Minneapolis, MN161KShares$130,3020.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny135KShares$109,1040.0% of portfolio
-
Black Rock Inc. New York, NY104KShares$84,1510.0% of portfolio
-
Royal Bank Of Canada Toronto, A680.4KShares$65,1240.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $44.6M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...